Literature DB >> 19050790

Proper detection of the nuclear shape: ways and significance.

G Bussolati1.   

Abstract

Shape and size of the nucleus, coupled with changes in chromatin amount and distribution, still remain the basic microscopic criteria for cytological diagnoses. Diagnostic recognition of the nuclear shape in pathological histology and cytology has been always based on the assumption that it is the content in nucleic acids, which determines the nuclear shape. The present review challenges this opinion, focuses on the structure, and functions of the nuclear envelope and on how these features can be exploited in diagnostic pathology. In particular, we will present the contribution of thee-dimensional modeling to the understanding of nuclear irregularities in breast cancer and papillary thyroid carcinomas. Specifically, it will be shown how tagging the nuclear membrane with anti-Emerin antibodies can represent an additional and valuable tool in the differential diagnosis of thyroid lesions. Finally, the prognostic importance of detecting irregularities of the nuclear shape in breast carcinomas by immunofluorescence staining for nuclear proteins will be discussed.

Entities:  

Mesh:

Year:  2008        PMID: 19050790

Source DB:  PubMed          Journal:  Rom J Morphol Embryol        ISSN: 1220-0522            Impact factor:   1.033


  9 in total

1.  Nuclear degradation dynamics in a nonapoptotic programmed cell death.

Authors:  Alla Yalonetskaya; Albert A Mondragon; Zackary J Hintze; Susan Holmes; Kimberly McCall
Journal:  Cell Death Differ       Date:  2019-07-08       Impact factor: 15.828

2.  Ubiquitin Immunostaining in Thyroid Neoplasms Marks True Intranuclear Cytoplasmic Pseudoinclusions and May Help Differentiate Papillary Carcinoma from NIFTP.

Authors:  Vincent Cracolici; Thomas Krausz; Nicole A Cipriani
Journal:  Head Neck Pathol       Date:  2018-03-06

3.  Emerin expression in well differentiated epithelial lesions of thyroid: implications in papillary thyroid carcinoma diagnosis and predicting malignant behavior.

Authors:  Ipek Coban; Asli Cakir; Tuba Dilay Kokenek Unal; Nuray Bassullu; Vildan Karpuz; Gulen Bulbul Dogusoy; Murat Alper
Journal:  Pathol Oncol Res       Date:  2014-08-14       Impact factor: 3.201

Review 4.  The nuclear envelope environment and its cancer connections.

Authors:  Kin-Hoe Chow; Rachel E Factor; Katharine S Ullman
Journal:  Nat Rev Cancer       Date:  2012-02-16       Impact factor: 60.716

Review 5.  Nuclear lamin functions and disease.

Authors:  Veronika Butin-Israeli; Stephen A Adam; Anne E Goldman; Robert D Goldman
Journal:  Trends Genet       Date:  2012-07-12       Impact factor: 11.639

Review 6.  Nuclear assembly as a target for anti-cancer therapies.

Authors:  Mátyás Gorjánácz
Journal:  Nucleus       Date:  2014-01-27       Impact factor: 4.197

Review 7.  The LEM-ESCRT toolkit: Repair and maintenance of the nucleus.

Authors:  Sapan Borah; Karthigeyan Dhanasekaran; Santosh Kumar
Journal:  Front Cell Dev Biol       Date:  2022-09-12

8.  CB2 receptor antibody signal specificity: correlations with the use of partial CB2-knockout mice and anti-rat CB2 receptor antibodies.

Authors:  Hai-Ying Zhang; Hui Shen; Chloe J Jordan; Qing-Rong Liu; Eliot L Gardner; Antonello Bonci; Zheng-Xiong Xi
Journal:  Acta Pharmacol Sin       Date:  2018-07-02       Impact factor: 6.150

9.  LEM4 confers tamoxifen resistance to breast cancer cells by activating cyclin D-CDK4/6-Rb and ERα pathway.

Authors:  Ang Gao; Tonghua Sun; Gui Ma; Jiangran Cao; Qingxia Hu; Ling Chen; Yanxin Wang; Qianying Wang; Jiafu Sun; Rui Wu; Qiao Wu; Jiaxi Zhou; Lin Liu; Junjie Hu; Jin-Tang Dong; Zhengmao Zhu
Journal:  Nat Commun       Date:  2018-10-09       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.